Patents by Inventor Padmavathy Vanguri

Padmavathy Vanguri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
    Publication number: 20110027241
    Abstract: A method of expressing at least one protein in an animal by intraperitoneal administration of mesenchymal stem cells genetically engineered with at least one polynucleotide encoding the at least one protein. The method may be employed in treating lysosomal storage disorders, such as Fabry Disease, or arthritic disorders, or hemophilia, for example.
    Type: Application
    Filed: October 15, 2010
    Publication date: February 3, 2011
    Inventors: Padmavathy Vanguri, Joseph D. Mosca
  • Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
    Publication number: 20110027237
    Abstract: A method of expressing at least one protein in an animal by intraperitoneal administration of mesenchymal stem cells genetically engineered with at least one polynucleotide encoding the at least one protein. The method may be employed in treating lysosomal storage disorders, such as Fabry Disease, or arthritic disorders, or hemophilia, for example.
    Type: Application
    Filed: October 15, 2010
    Publication date: February 3, 2011
    Inventors: Padmavathy Vanguri, Joseph D. Mosca
  • Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
    Publication number: 20100255111
    Abstract: A method of expressing at least one protein in an animal by intraperitoneal administration of mesenchymal stem cells (or genetically engineered mesenchymal stem cells) with at least one polynucleotide encoding at least one protein. The method may be employed, for example, in treating lysosomal storage disorders, such as Fabry Disease, or arthritic disorders, or hemophilia, or diabetes.
    Type: Application
    Filed: June 3, 2009
    Publication date: October 7, 2010
    Applicant: OSIRIS THERAPEUTICS, INC.
    Inventors: PADMAVATHY VANGURI, JOSEPH D. MOSCA
  • ADIPOSE TISSUE DERIVED STROMAL CELLS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20100119496
    Abstract: The present invention relates to a treatment of neural injury and neurodegenerative diseases. Also included in the present invention is the use of adipose tissue derived stromal cells for the treatment of neural injury (stroke, traumatic brain injury, spinal cord injury) and neurodegeneration (i.e. Parkinson's disease).
    Type: Application
    Filed: August 7, 2009
    Publication date: May 13, 2010
    Applicant: ARTECEL, INC.
    Inventors: William O. Wilkison, Jeffrey M. Gimble, Padmavathy Vanguri
  • Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells
    Publication number: 20090257989
    Abstract: A method of expressing at least one protein in an animal by intraperitoneal administration of mesenchymal stem cells genetically engineered with at least one polynucleotide encoding the at least one protein. The method may be employed in treating lysosomal storage disorders, such as Fabry Disease, or arthritic disorders, or hemophilia, for example.
    Type: Application
    Filed: May 1, 2009
    Publication date: October 15, 2009
    Inventors: Padmavathy Vanguri, Joseph D. Mosca
  • Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells
    Publication number: 20090238802
    Abstract: A method of expressing at least one protein in an animal by intraperitoneal administration of mesenchymal stem cells genetically engineered with at least one polynucleotide encoding the at least one protein. The method may be employed in treating lysosomal storage disorders, such as Fabry Disease, or arthritic disorders, or hemophilia, for example.
    Type: Application
    Filed: January 28, 2009
    Publication date: September 24, 2009
    Inventors: Padmavathy Vanguri, Joseph D. Mosca
  • Adipose tissue derived stromal cells for the treatment of neurological disorders
    Patent number: 7582292
    Abstract: The present invention relates to a treatment of neural injury and neurodegenerative diseases. Also included in the present invention is the use of adipose tissue derived stromal cells for the treatment of neural injury (stroke, traumatic brain injury, spinal cord injury) and neurodegeneration (i.e. Parkinson's disease).
    Type: Grant
    Filed: November 23, 2005
    Date of Patent: September 1, 2009
    Assignee: Artecel, Inc.
    Inventors: William O. Wilkison, Jeffrey M. Gimble, Padmavathy Vanguri
  • Adipose tissue derived stromal cells for the treatment of neurological disorders
    Publication number: 20070104697
    Abstract: The present invention relates to a treatment of neural injury and neurodegenerative diseases. Also included in the present invention is the use of adipose tissue derived stromal cells for the treatment of neural injury (stroke, traumatic brain injury, spinal cord injury) and neurodegeneration (i.e. Parkinson's disease).
    Type: Application
    Filed: November 23, 2005
    Publication date: May 10, 2007
    Inventors: William Wilkison, Jeffrey Gimble, Padmavathy Vanguri
  • Expansion of neural stem cells with LIF
    Publication number: 20050214941
    Abstract: The present invention encompasses methods and compositions for enhancing the growth of neural stem cells (NSCs).
    Type: Application
    Filed: March 16, 2005
    Publication date: September 29, 2005
    Inventors: Smita Bhonsale, Padmavathy Vanguri
  • Compositions and methods relating to culturing neural stem cells with bone marrow stromal cells
    Publication number: 20050176141
    Abstract: The present invention encompasses methods and compositions for enhancing the growth of neural stem cells. Methods for modulating MHC molecule expression on a neural stem cell (NSC) are also included in the invention.
    Type: Application
    Filed: February 1, 2005
    Publication date: August 11, 2005
    Inventors: Padmavathy Vanguri, Smita Savant-Bhonsale
  • Intraperitoneal delivery of genetically engineered mesenchymal stem cells
    Publication number: 20040033217
    Abstract: A method of expressing at least one protein in an animal by intraperitoneal administration of mesenchymal stem cells genetically engineered with at least one polynucleotide encoding the at least one protein. The method may be employed in treating lysosomal storage disorders, such as Fabry Disease, or arthritic disorders, or hemophilia, for example.
    Type: Application
    Filed: May 28, 2003
    Publication date: February 19, 2004
    Inventors: Padmavathy Vanguri, Joseph D. Mosca
  • Immunocompetent animals including xenogeneic implants of mesenchymal stem cells
    Publication number: 20020129392
    Abstract: An immunocompetent post-natal animal of a first species having had administered thereto, such as by implantation or injection, mesenchymal stem cells which were obtained from an animal of a second species. In one embodiment, an immunocompetent mouse has human mesenchymal stem cells implanted therein.
    Type: Application
    Filed: November 14, 2001
    Publication date: September 12, 2002
    Applicant: Osiris Therapeutics, Inc.
    Inventors: Padmavathy Vanguri, Robert Deans